Presolicitation Notice – Z-SPEC Z-max X-Ray Fluorescence (XRF) Instrument

The U.S. Food and Drug Administration’s Office of Acquisition and Grant Services is issuing a presolicitation notice for the Z-SPEC Z-max X-Ray Fluorescence (XRF) Instrument under solicitation number NOI-FDA-133864, with a response deadline of July 14, 2026. This action is part of the procurement process governed by NAICS code 334516, which classifies the acquisition under instruments and laboratory equipment manufacturing. The place of performance is designated as Irvine, California, with the contracting office located in Rockville, Maryland. The primary point of contact for inquiries is Freshta Javid, reachable via email or phone, and all responses must be submitted through the SAM.gov platform prior to the stated deadline. No set-aside classification is applied to this acquisition, indicating it is open to all eligible businesses without preference for small businesses, veteran-owned firms, or other designated categories. Although the presolicitation notice indicates intent to procure, detailed technical specifications, evaluation criteria, delivery schedules, pricing information, contract clauses, packaging requirements, inspection standards, and representations or certifications are not included in the available documentation. The notice serves to inform industry of an upcoming procurement opportunity and solicit feedback or interest but does not constitute a request for proposals or provide sufficient detail to prepare a bid. No estimated contract value is disclosed, and access to additional sections of the full solicitation such as statement of work, evaluation factors, or special requirements is restricted or unavailable.